All together, these observations illustrate the potency of PD-L silenced DCs with adoptive transfer of MiHA-specific CD8+ T cells, which should be further explored for improving an antitumor effect in a relevant tumor therapy model. The gene discussed is CD8A; the disease is neoplasm.